Sign in Pull a receipt

CTMX

CytomX Therapeutics, Inc.

Healthcare · Biotechnology

$137.47 sample

-1.42 (-1.02%) 1D

Market cap

$470.2B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-21

Alerts

8

Price$137.47 -9.48% 3M daily closessample

156.66136.03

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider sell: General Counsel
Oct 14INSInsider sell: General Counsel
Oct 07INSInsider sell: General Counsel
Sep 29INSInsider sell: 10% owner
Sep 21SECDEF 14A filed
Sep 15INSInsider sell: EVP, Operations
Sep 04INSInsider buy: Chief Executive Officer
Aug 28SECForm 144 filed

Sign up to see the real CTMX record →

Company facts

SEC EDGAR registration

Name: CytomX Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -43sample, -100 to +100
Reporting currency: USD

Who is positioning in CTMX

sample

Insiders: 28 insider transactions over 90 days, net selling, $537.9M
Congress: 5 members traded over 90 days
Institutions · 13F: 28 funds hold $8.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$16.3B +12.4% y/y

Q4 2024Q3 2026

Inventory$10.0B +13.3% y/y

Q4 2024Q3 2026

Accounts receivable$7.4B +16.0% y/y

Q4 2024Q3 2026

Total debt$19.5B +14.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $336.4B +9.8% 3M
Sample peer B: $70.3B +14.5% 3M
Sample peer C: $219.9B +4.3% 3M
Sample peer D: $426.3B -10.0% 3M
Sample peer E: $51.8B -3.9% 3M